NYSE: MSCIMsci Inc Stock
$571.21-1.44 (-0.25%)
Updated May 20, 2025
MSCI Price
$571.21
Fair Value Price
N/A
Market Cap
$44.20B
52 Week Low
$475.32
52 Week High
$642.45
P/E
39.18x
P/B
-46.11x
P/S
15.02x
PEG
3.26x
Dividend Yield
0.56%
Revenue
$2.92B
Earnings
$1.14B
Gross Margin
82.1%
Operating Margin
53.96%
Profit Margin
39.1%
Debt to Equity
-6.58
Operating Cash Flow
$2B
Beta
1.16
Next Earnings
Jul 21, 2025
Ex-Dividend
N/A
Next Dividend
N/A
MSCI Overview
MSCI Incorporated provides investment decision support tools that clients use to manage investment processes. Its indexes are used in various areas of the investment process, including indexed product creation, performance benchmarking, portfolio construction and rebalancing, and asset allocation. The company serves asset owners and managers, financial intermediaries, wealth managers, real estate professionals, and corporations. MSCI was incorporated in 1998 and is headquartered in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MSCI's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Financial Datum & Stock Exchange
Industry Rating
C
MSCI
Ranked#4 of 11
Ranked#4 of 11
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $310.44 | B | |
| $81.83 | C | |
| $39.75 | C |
Be the first to know about important MSCI news, forecast changes, insider trades & much more!
MSCI News
Overview
Due Diligence Score
–
Industry Average (39)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MSCI scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MSCI ($571.21) is trading above its intrinsic value of $139.29, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MSCI is poor value based on its earnings relative to its share price (39.18x), compared to the US market average (25.56x)
P/E vs Market Valuation
MSCI is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more MSCI due diligence checks available for Premium users.
Valuation
MSCI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
39.18x
Industry
36.42x
Market
25.56x
MSCI is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MSCI is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
MSCI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-46.11x
Industry
5.34x
MSCI price to earnings growth (PEG)
For valuing profitable companies with growth potential
MSCI is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
MSCI's financial health
Profit margin
Revenue
$745.8M
Net Income
$288.6M
Profit Margin
38.7%
MSCI's Earnings (EBIT) of $1.58B... subscribe to Premium to read more.
Interest Coverage Financials
MSCI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.3B
Liabilities
$6.3B
Debt to equity
-6.58
MSCI's short-term liabilities ($1.47B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MSCI's long-term liabilities ($4.84B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MSCI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MSCI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$301.7M
Investing
-$32.9M
Financing
-$321.7M
MSCI's operating cash flow ($1.50B)... subscribe to Premium to read more.
Debt Coverage Financials
MSCI vs Financial Datum & Stock Exchange Stocks
Msci Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.